D-0043-2025 Class II Ongoing
FDA drug recall D-0043-2025 was initiated by Cipla USA, Inc. on Oct 23, 2024 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets. The recall status is ongoing. Affected quantity: 1,875 boxes (cipla and exlan).
Recall details
- Product Type
- Drugs
- Report Date
- Nov 20, 2024
- Initiation Date
- Oct 23, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,875 boxes (cipla and exlan)
Product description
Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98
Reason for recall
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Distribution pattern
USA nationwide.
Code information
Lot # NB240316, Exp 12/31/25
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0043-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026